Insight on EU’s safety features of unique identifier & anti-tampering device on outer packaging require for medicines
As of 9 February 2019, most prescription medicines and some over-the-counter medicines for human use supplied in the European Union are required... Read More
Pfizer’s launches awareness and advocacy program on antibiotic resistance
Posted on28 Jan 2019
Comments0
ABOUT ICMR PFIZER CENTRE FOR AMR RESEARCH & EDUCATION In February 2018, the Indian Council of Medical Research (ICMR) and Pfizer signed... Read More
Pfizer and GlaxoSmithKline to merge consumer healthcare units
Pfizer Inc. and GlaxoSmithKline plc have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.... Read More
Boehringer Ingelheim’s ASF COMBAT market launch: East to use Tool in prevention of African swine fever
Boehringer Ingelheim has developed ASF COMBAT (ASF Comprehensive Online Management and Biosecurity Assessment Tool). This tool enables pig producers to evaluate areas... Read More
2018 Pharma Deal: Sanofi’s agreement to buy Bioverati @ $10.9 billion
Posted on18 Dec 2018
TagsBioverati, global pharma deals, global pharma licensing deal, pharma acquisition, pharma deal, Sanofi
Comments0
Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive... Read More
2018 Pharma Deal: Novartis’ acquisition of AveXis: $8.1 billion
Posted on18 Dec 2018
TagsAveXis, global pharma deals, global pharma licensing deal, novartis, pharma acquisition, pharma deal
Comments0
Novartis has agreed to acquire the US-based Nasdaq-listed clinical stage gene therapy company for USD 218 per share or a total of... Read More
AbbVie, Pfizer’s non-exlcusive licencing agreement for biosimilar Humira
Posted on17 Dec 2018
TagsAbbVie, Amgen, biosimilar of sandoz, Boehringer Ingelheim, Fresenius Kabi, humira, Merck, Momenta, Mylan, novartis, Novartis’ Sandoz, Samsung Bioepis, sandoz
Comments0
AbbVie has granted a non-exclusive patent license allowing Pfizer to sell its Humira (adalimumab) biosimilar in many countries around the world, halting... Read More
Novartis app for opium addicts gets US approval
Sandoz Inc., a division of Swiss pharmaceutical giant Novartis, and US company Pear Therapeutics announced this week that the the U.S. Food... Read More
AMAG Pharmaceuticals to Acquire Perosphere and Its Anticoagulant
Posted on17 Dec 2018
Comments0
AMAG Pharmaceuticals, Inc. will acquire Perosphere Inc. to leverage its expertise in hematology. The deal will provide the company the rights to... Read More
Insight on USFDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor
Posted on29 Nov 2018
Comments0
The U.S. Food and Drug Administration (FDA) today approved Vitrakvi® (larotrectinib), the first ever oral TRK inhibitor, for the treatment of adult... Read More